Drug issues [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, October 1, 1987--Orphan Drug Amendments of 1987 (H.R. 3349), October 5, 1987--Generic Animal Drug and Patent Term Restoration Act (H.R. 3120), May 16, 1988--Consumer Product Safe Testing Act (H.R. 1635).

Drug testing in the workplace [microform] : hearings before the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session ... April 9 and May 13, 1987.

United States. Congress. Senate. Committee on the Judiciary.

January 1989

"Serial no. J-100-16."CIS Microfiche Accession Numbers: CIS 89 S521-19Bibliography: p. 295-296.Micro...

Prevention of drug abuse [microform] : hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

Reuse of record except for individual research requires license from Congressional Information Servi...

The worldwide drug situation and international narcotics control programs [microform] : hearing before the Committee on Foreign Affairs, House of Representatives, One hundredth Congress, first session, March 5, 1987.

United States. Congress. House. Committee on Foreign Affairs.

January 1987

CIS Microfiche Accession Numbers: CIS 87 H381-53Microfiche.Mode of access: Internet

Medical devices and drug issues [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session, April 8, 21, and May 4, 1987.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1987

"Serial no. 100-34."CIS Microfiche Accession Numbers: CIS 88 H361-7Includes bibliographies.Microfich...

Drug legislation [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

"Serial no. 98-67."CIS Microfiche Accession Numbers: CIS 84 H361-11Includes bibliographical referenc...

Therapeutic drugs for AIDS [microform] : development, testing, and availability : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, April 28 and 29, 1988.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

CIS Microfiche Accession Numbers: CIS 89 H401-20Includes bibliographies.Microfiche.Mode of access: I...

Brand names and generic drugs, 1974 [microform] : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.

United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health.
United States. Drug Bioequivalence Study Panel. Drug bioequivalence. 1974.

January 1974

Reuse of record except for individual research requires license from Congressional Information Servi...

Pharmaceutical innovation--promises and problems [microform] : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment and the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, April 27, 1981.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources, Agriculture Research, and Environment.
United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight.

January 1982

"No. 145."CIS Microfiche Accession Numbers: CIS 83 H701-23Includes bibliographical references.Microf...

Tamper-resistant packaging for over-the-counter drugs [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, October 15, 1982.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 97-176."CIS Microfiche Accession Numbers: CIS 83 H361-14Includes bibliographical referen...

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

Item 1019-A, 1019-B (microfiche)."Serial no. 98-67."Distributed to some depository libraries in micr...

Drug safety amendments of 1976 [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session ....

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment.

January 1976

Reuse of record except for individual research requires license from Congressional Information Servi...

Competitive problems in the pharmaceutical drug industry [microform] : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights.

January 1989

"Serial no. J-100-40."CIS Microfiche Accession Numbers: CIS 89 S521-9Includes bibliographies.Microfi...

Prescription drug price increases [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1986

"Serial no. 99-58."CIS Microfiche Accession Numbers: CIS 86 H361-28Includes bibliographies.Microfich...

Drug abuse treatment [microform] : hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-fifth Congress, second session ...

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

Reuse of record except for individual research requires license from Congressional Information Servi...

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1990

Item 1019-A, 1019-B (MF)"Serial no. 101-130."Shipping list no.: 90-455-P.Distributed to some deposit...

Drug testing in the workplace [microform] : hearings before the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session ... April 9 and May 13, 1987.

United States. Congress. Senate. Committee on the Judiciary.

January 1989

"Serial no. J-100-16."CIS Microfiche Accession Numbers: CIS 89 S521-19Bibliography: p. 295-296.Micro...

Prevention of drug abuse [microform] : hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

Reuse of record except for individual research requires license from Congressional Information Servi...

The worldwide drug situation and international narcotics control programs [microform] : hearing before the Committee on Foreign Affairs, House of Representatives, One hundredth Congress, first session, March 5, 1987.

United States. Congress. House. Committee on Foreign Affairs.

January 1987

CIS Microfiche Accession Numbers: CIS 87 H381-53Microfiche.Mode of access: Internet

Medical devices and drug issues [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session, April 8, 21, and May 4, 1987.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1987

"Serial no. 100-34."CIS Microfiche Accession Numbers: CIS 88 H361-7Includes bibliographies.Microfich...

Drug legislation [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

"Serial no. 98-67."CIS Microfiche Accession Numbers: CIS 84 H361-11Includes bibliographical referenc...

Therapeutic drugs for AIDS [microform] : development, testing, and availability : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, April 28 and 29, 1988.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

CIS Microfiche Accession Numbers: CIS 89 H401-20Includes bibliographies.Microfiche.Mode of access: I...

Brand names and generic drugs, 1974 [microform] : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.

United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health.
United States. Drug Bioequivalence Study Panel. Drug bioequivalence. 1974.

January 1974

Reuse of record except for individual research requires license from Congressional Information Servi...

Pharmaceutical innovation--promises and problems [microform] : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment and the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, April 27, 1981.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources, Agriculture Research, and Environment.
United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight.

January 1982

"No. 145."CIS Microfiche Accession Numbers: CIS 83 H701-23Includes bibliographical references.Microf...

Tamper-resistant packaging for over-the-counter drugs [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, October 15, 1982.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 97-176."CIS Microfiche Accession Numbers: CIS 83 H361-14Includes bibliographical referen...

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1983

Item 1019-A, 1019-B (microfiche)."Serial no. 98-67."Distributed to some depository libraries in micr...

Drug safety amendments of 1976 [microform] : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session ....

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment.

January 1976

Reuse of record except for individual research requires license from Congressional Information Servi...

Competitive problems in the pharmaceutical drug industry [microform] : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights.

January 1989

"Serial no. J-100-40."CIS Microfiche Accession Numbers: CIS 89 S521-9Includes bibliographies.Microfi...

Prescription drug price increases [microform] : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1986

"Serial no. 99-58."CIS Microfiche Accession Numbers: CIS 86 H361-28Includes bibliographies.Microfich...

Drug abuse treatment [microform] : hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-fifth Congress, second session ...

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

Reuse of record except for individual research requires license from Congressional Information Servi...

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1990

Item 1019-A, 1019-B (MF)"Serial no. 101-130."Shipping list no.: 90-455-P.Distributed to some deposit...

Drug testing in the workplace [microform] : hearings before the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session ... April 9 and May 13, 1987.

United States. Congress. Senate. Committee on the Judiciary.

January 1989

"Serial no. J-100-16."CIS Microfiche Accession Numbers: CIS 89 S521-19Bibliography: p. 295-296.Micro...

Prevention of drug abuse [microform] : hearings before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

Reuse of record except for individual research requires license from Congressional Information Servi...

The worldwide drug situation and international narcotics control programs [microform] : hearing before the Committee on Foreign Affairs, House of Representatives, One hundredth Congress, first session, March 5, 1987.

United States. Congress. House. Committee on Foreign Affairs.

January 1987

CIS Microfiche Accession Numbers: CIS 87 H381-53Microfiche.Mode of access: Internet

Abstract

Extracted data

Abstract

Extracted data

Related items

Related items